OR WAIT null SECS
© 2022 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
GlaxoSmithKline (GSK) and University College London's Institute of Ophthalmology have agreed a deal in which the Institute will investigate the potential of compounds provided by GSK's ophthalmic unit, Ophthiris.